Physician

Alexander Edward Glick, M.D.

According to 2025 Medicare claims, Alexander Glick, M.D. (NPI: 1598081911) practices hematology/oncology in the Punta Gorda, FL market, with the plurality of this provider's patient population coming from Charlotte, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33980-2012. Glick is affiliated with the Adirondacks ACO, LLC (ACO ID: A2193), participating under the MSSP model.

Glick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,735 traditional Medicare patients, billed 422,281 HCPCS/CPT codes, and received $7,648,765 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,381 prescription claims across 461 beneficiaries totaling $9,182,016 in drug costs, led by Revlimid (Lenalidomide). DME data shows 22 claims. Open Payments data shows 132 records totaling $171,055. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $102,571 to $7,648,765. Similarly, Part D prescription costs have risen steadily, from $119,292 to $9,182,016. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,329 to $4,296.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	326	3,270	$102,571
2017	1,587	80,851	$1,224,106
2018	2,355	421,733	$6,438,317
2019	2,573	616,489	$9,176,747
2020	2,244	478,367	$8,588,508
2021	2,382	426,665	$8,551,693
2022	2,110	372,474	$7,793,577
2023	1,946	400,454	$7,134,204
2024	1,735	422,281	$7,648,765

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	48	215	$119,292
2016	23	78	$59,700
2017	71	238	$168,253
2018	298	1,226	$2,550,798
2019	456	2,271	$5,640,505
2020	426	2,178	$6,261,331
2021	403	2,131	$6,553,497
2022	446	2,298	$6,942,540
2023	454	2,344	$7,567,480
2024	461	2,381	$9,182,016

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	41	$6,064
2019	N/R	72	$8,248
2020	N/R	13	$2,042
2021	N/R	37	$1,478
2022	N/R	26	$1,419
2023	N/R	44	$2,597
2024	N/R	22	$1,000

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	832	1,929	$94
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	721	1,423	$13
96372	Injection of drug or substance under skin or into muscle	351	1,097	$10
36415	Insertion of needle into vein for collection of blood sample	1,283	3,469	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,238	3,599	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	127	3,332	$2,200,739
Xtandi	Enzalutamide	55	1,650	$782,553
Pomalyst	Pomalidomide	34	952	$779,972
Jakafi	Ruxolitinib Phosphate	36	1,080	$623,886
Kisqali	Ribociclib Succinate	29	812	$468,634

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$820
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	11	$180

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	117	$4,309	Janssen Scientific Affairs, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	15	$166,746	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander Edward Glick, M.D.?

Tedicare shows public-source Medicare data for Alexander Edward Glick, M.D. (NPI 1598081911), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Edward Glick, M.D. have ACO affiliation data?

Alexander Edward Glick, M.D. is shown with ACO affiliation data for Adirondacks ACO, LLC (MSSP, ACO ID A2193).

What billing organization is linked to Alexander Edward Glick, M.D.?

Alexander Edward Glick, M.D. is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Alexander Edward Glick, M.D. have Open Payments data?

Alexander Edward Glick, M.D. has 132 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.